Bourgeon Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bourgeon Capital Management’s Portfolio BTAL Stock Details BTAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,000	Closed	-$71K	–	284
2021 Q4	$71K	Buy	4,000 +1,700	+74%	+$28.9K	0.01%	138
2021 Q3	$39K	Hold	2,300	–	–	0.01%	177
2021 Q2	$39K	Buy	+2,300	New	+$38.9K	0.01%	175

Other funds holding BTAL

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

TWM

TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

CWG

Cornerstone Wealth Group Huntersville, North Carolina $1.56B AUM 22.37% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

APA

Astoria Portfolio Advisors New York $470M AUM 21.04% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Bourgeon Capital Management's BTAL Position: Q1 2022 in Review

Bourgeon Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2022, closing a stake of 4,000 shares — an estimated $71K sold.

Bourgeon Capital Management first reported a position in BTAL in Q2 2021 and held it in 3 quarters. The position peaked at $71K in Q4 2021. 35 funds tracked by Wall St. Rank hold BTAL as of Q1 2022.

Bourgeon Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2022 after selling out during the quarter.
Bourgeon Capital Management sold 4,000 AGF US Market Neutral Anti-Beta Fund shares in Q1 2022, an estimated $71K.
Bourgeon Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2021 and held it in 3 quarters.
Bourgeon Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $71K in Q4 2021.
35 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2022.

Based on Bourgeon Capital Management's 13F filing for Q1 2022, filed 3 May 2022.